循环肿瘤细胞检测在恶性肿瘤治疗及预后评估中的研究进展  

Advances in the Research of Circulating Tumor Cell Detection for Malignant Tumor Treatment and Prognostic Assessment

作　　者：韦春莹 钟晓刚[2] 李松霖 

机构地区：[1]右江民族医学院,临床医学院,广西 百色 [2]广西壮族自治区人民医院,结直肠肛门外科,广西 南宁

出　　处：《临床医学进展》2024年第11期721-726,共6页Advances in Clinical Medicine

摘　　要：循环肿瘤细胞(CTCs)作为恶性肿瘤患者血液中的重要生物标志物,其检测技术的不断发展为肿瘤的精准治疗和预后评估提供了新的视角。本综述总结了CTCs的检测技术的特点及近年来CTCs检测在常见恶性肿瘤治疗中的研究进展,探讨其临床应用以及对恶性肿瘤治疗反应评估和患者生存期的预测价值。旨在为进一步完善CTCs的检测技术及为其在科研和临床工作中提供更多的参考价值。Circulating tumor cells (CTCs), as critical biomarkers present in the bloodstream of patients with malignant tumors, have gained significant attention due to the evolving advancements in their detection technologies. This review summarizes the characteristics of CTC detection techniques and highlights recent progress in applying these methods to common malignancies for therapy guidance and prognostic assessment. It explores the clinical utility of CTCs in evaluating treatment response and predicting survival outcomes in cancer patients. The aim is to contribute towards refining CTC detection methodologies and enhancing their applicability in both research and clinical practice, thereby offering enhanced reference value.

关 键 词：循环肿瘤细胞 恶性肿瘤 治疗 个体化医疗 

分 类 号：R73[医药卫生—肿瘤]